has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 3.0207 crores during the period ended December 31, 2021 as compared to Rs. 5.3855 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 0.0480 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.0192 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 0.31 for the period ended December 31, 2021 as compared to Rs. 0.12 for the period ended September 30, 2021.
Total Income | ₹ 3.0207 crs | ₹5.3855 crs | -43.91% |
Net Profit | ₹0.0480 crs | ₹0.0192 crs | 150.00% |
EPS | ₹0.31 | ₹0.12 | 158.33% |
Financial Results (Q3 FY2022) - YoY Comparison The company has reported total income of Rs. 3.0207 crores during the period ended December 31, 2021 as compared to Rs.4.4194 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.0480 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.2070 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.0.31 for the period ended December 31, 2021 as compared to Rs.1.32 for the period ended December 31, 2020.
Total Income | ₹ 3.0207 crs | ₹4.4194 crs | -31.65% |
Net Profit | ₹0.0480 crs | ₹0.2070 crs | -76.81% |
EPS | ₹0.31 | ₹1.32 | -76.52% |
Financial Results (9 Months Ended FY2022) - YoY Comparison The company has reported total income of Rs.11.5941 crores during the 9 Months period ended December 31, 2021 as compared to Rs.7.4429 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.1043 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.0.2847 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.0.67 for the 9 Months period ended December 31, 2021 as compared to Rs.1.82 for the 9 Months period ended December 31, 2020.
Total Income | ₹11.5941 crs | ₹7.4429 crs | 55.77% |
Net Profit | ₹0.1043 crs | ₹0.2847 crs | -63.36% |
EPS | ₹0.67 | ₹1.82 | -63.19% |
Source : Equity Bulls
Keywords
ShukraPharmaceuticals
Q3FY22
9MFY22
ResultUpdate